DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $59,703,000 | +0.9% | 413,372 | -0.1% | 1.85% | -0.6% |
| Q2 2019 | $59,157,000 | +2.1% | 413,916 | -5.7% | 1.86% | -2.1% |
| Q1 2019 | $57,922,000 | +29.5% | 438,736 | +1.1% | 1.90% | +12.4% |
| Q4 2018 | $44,730,000 | -4.8% | 433,772 | +0.3% | 1.69% | +16.4% |
| Q3 2018 | $46,990,000 | +0.4% | 432,446 | -8.8% | 1.45% | -4.1% |
| Q2 2018 | $46,797,000 | -8.3% | 474,232 | -9.0% | 1.52% | -11.5% |
| Q1 2018 | $51,026,000 | +5.3% | 521,152 | -0.2% | 1.71% | +4.0% |
| Q4 2017 | $48,465,000 | +2.6% | 522,138 | -5.2% | 1.65% | -2.5% |
| Q3 2017 | $47,227,000 | -7.9% | 550,562 | -9.4% | 1.69% | -10.2% |
| Q2 2017 | $51,302,000 | -4.5% | 607,920 | -3.2% | 1.88% | -9.2% |
| Q1 2017 | $53,720,000 | +5.6% | 628,082 | -3.9% | 2.07% | -7.3% |
| Q4 2016 | $50,857,000 | – | 653,344 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |